- Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
-
Lau GK, Leung N
- KMID: 1717327
- Korean J Hepatol.
- 2010 Sep;16(3):315-320.
- doi: 10.3350/kjhep.2010.16.3.315
BACKGROUND/AIMS: Clevudine is a pyrimidine analogue with potent activity against hepatitis B virus (HBV) replication in vitro. In a previous pivotal phase III clinical study, 24 weeks treatment with clevudine... -
- CITED
-
- Close
- SHARE
-
- Close
